ZimVie, the former spine spinoff of Zimmer Biomet, is reportedly weighing options for a potential sale, Bloomberg reported June 25.
Five notes:
1. ZimVie is reportedly working with an adviser to explore its options after receiving interest from potential buyers.
2. Discussions for a sale are reportedly in their early stages, and the company may still decide against a sale, Bloomberg reported.
3. A representative for ZimVie declined to comment to Bloomberg.
4. Zimmer Biomet announced its plans to create a dental and spine spinoff company in February 2021. The spinoff was completed in March 2022.
5. ZimVie closed on the sale of its spine business to H.I.G. Capital in April and began focusing solely on dental implants. The sale followed a financially rocky year for the company's spine business.